Influenza News and Research

RSS

Influenza (the flu) is a contagious respiratory illness caused by influenza viruses. It can cause mild to severe illness, and at times can lead to death. The best way to prevent the flu is by getting a flu vaccination each year. Every year in the United States, on average 5% to 20% of the population gets the flu; more than 200,000 people are hospitalized from flu complications, and; about 36,000 people die from flu-related causes. Some people, such as older people, young children, and people with certain health conditions, are at high risk for serious flu complications.

Potential SARS-CoV-2 therapy based on banana protein

A study praising the development of a potential treatment that might be applied to combat all recognized influenza strains was published online on January 13th, 2020.

25 Oct 2022

Tiny DNA strand net in a low-cost test platform traps COVID-19 virus

According to a new study, tiny nets made of DNA strands can capture the spike protein of the virus that causes COVID-19, illuminating it for a quick yet accurate diagnostic test and preventing it from infecting cells, suggesting a new potential path to antiviral treatment.

26 Sep 2022

Scientists create new live-attenuated influenza vaccine technique over pathogens

The use of attenuated, live viruses as vaccines is a potential method to minimize the effects of viral infectious diseases, such as influenza.

8 Jul 2022

Researchers target human protein to combat SARS-CoV-2 and other viruses

People are realizing now, more than two years into the COVID-19 disease outbreak, that the “new normal” will most likely involve practicing to coexist with SARS-CoV-2.

1 Jul 2022

RNA binding proteins in T cells help generate an effective immune response

Two RNA binding proteins have been discovered to be the key to a greater immune reaction to influenza in mice, according to researchers at the Babraham Institute.

29 Apr 2022

Scientists create powerful new method for generating protein drugs

A team of scientists has created a powerful new method for generating protein drugs. Using computers, they designed molecules that can target important proteins in the body, such as the insulin receptor, as well as vulnerable proteins on the surface of viruses.

28 Mar 2022

Macrophages show altered inflammatory, metabolic expression months after mild COVID-19

There is a lack of understanding as to why some people suffer from long-lasting symptoms after COVID-19 infection.

15 Mar 2022

OxDX raises £2.6M pre-seed funding to develop AI powered rapid diagnostic technology

OxDX has raised £2.6m in pre-seed funding for its AI powered diagnostic technology that can recognise and identify specific species and strains of viruses.

15 Feb 2022

Researchers discover a sustainable approach for drug development

Although several people think of medicines as purely synthetic compounds, nature is an important element of most of the medications humans depend on.

4 Feb 2022

Study identifies respiratory syncytial viral protein that mediates RSV-induced autophagy

A viral protein might contain information that could be used to avoid pneumonia due to the body’s overactive response to respiratory viruses, such as COVID-19.

20 Jan 2022

Infant's immune system may be better than the adult immune system

As any parent knows, infants are prone to getting respiratory infections. But a new study shows that the infant immune system is stronger than most people think and beats the adult immune system at fighting off new pathogens.

13 Dec 2021

Scientists unravel the structure of octopus-like Lassa viral polymerase

Endemic in Western African countries, Lassa virus is transmitted to humans through food or household items that are contaminated with the urine or faeces of Mastomys rats.

7 Dec 2021

Study reveals mechanism by which infections strengthen the immune system

Over time, the immune system in humans weakens making older adults more prone to infections. This leaves researchers with the puzzling dilemma of retaining health throughout the lifespan.

7 Dec 2021

New nanoparticle adjuvant could lead to more powerful vaccines

A common strategy to make vaccines more powerful is to deliver them along with an adjuvant -; a compound that stimulates the immune system to produce a stronger response.

6 Dec 2021

Nanoparticles mimicking flu viruses to deliver large biological drug molecules

Nanoengineers from the University of California San Diego recently created a new and potentially efficient means to deliver messenger RNA (mRNA) into cells.

2 Dec 2021

New CRISPR technology could improve diagnostic tests for COVID-19

A new type of CRISPR platform that leverages the benefits of a compact RNA-editing protein could result in enhanced diagnostic tests for COVID-19.

2 Dec 2021

Study analyzes response of individuals from diverse populations to infections

A recent study has identified differences in immune pathway activation to influenza infection between people of European and African genetic ancestry.

2 Dec 2021

Correction of immune system's faulty timing may offer a new strategy to prevent severe COVID-19

Once an infection is under control, the body normally uses a biochemical messenger known as TGFβ to downgrade its immune response.

27 Oct 2021

Poor systemic immune responses and elevated MAIT cell activation linked to fatal COVID-19 infections

The mortality rate of COVID-19 patients requiring mechanical ventilation is 30-40%, however, the immunological factors associated with death in critically ill COVID-19 patients are poorly understood.

17 Sep 2021

Research identifies an unnoticed site for priming of CD8+ T cells—the spleen

CD8+ T cells, also called “killer” T cells, are the killers of the immune system. Upon being primed, they look for and kill cancerous cells or virus-infected cells.

14 Sep 2021

Influenza News and Research

Potential SARS-CoV-2 therapy based on banana protein

Tiny DNA strand net in a low-cost test platform traps COVID-19 virus

Scientists create new live-attenuated influenza vaccine technique over pathogens

Researchers target human protein to combat SARS-CoV-2 and other viruses

RNA binding proteins in T cells help generate an effective immune response

Scientists create powerful new method for generating protein drugs

Macrophages show altered inflammatory, metabolic expression months after mild COVID-19

OxDX raises £2.6M pre-seed funding to develop AI powered rapid diagnostic technology

Researchers discover a sustainable approach for drug development

Study identifies respiratory syncytial viral protein that mediates RSV-induced autophagy

Infant's immune system may be better than the adult immune system

Scientists unravel the structure of octopus-like Lassa viral polymerase

Study reveals mechanism by which infections strengthen the immune system

New nanoparticle adjuvant could lead to more powerful vaccines

Nanoparticles mimicking flu viruses to deliver large biological drug molecules

New CRISPR technology could improve diagnostic tests for COVID-19

Study analyzes response of individuals from diverse populations to infections

Correction of immune system's faulty timing may offer a new strategy to prevent severe COVID-19

Poor systemic immune responses and elevated MAIT cell activation linked to fatal COVID-19 infections

Research identifies an unnoticed site for priming of CD8+ T cells—the spleen

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics